Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cloud Computing | 2 | 2021 | 214 | 0.32 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.22 | Why? |
| Genome, Bacterial | 2 | 2017 | 446 | 0.21 | Why? |
| Tryptophan Synthase | 1 | 2017 | 2 | 0.18 | Why? |
| Microbiota | 2 | 2020 | 1240 | 0.18 | Why? |
| Nanopores | 1 | 2019 | 128 | 0.17 | Why? |
| Metagenomics | 3 | 2020 | 823 | 0.17 | Why? |
| Whole Genome Sequencing | 4 | 2021 | 3239 | 0.17 | Why? |
| United Kingdom | 6 | 2021 | 18046 | 0.16 | Why? |
| Genomics | 4 | 2021 | 3118 | 0.15 | Why? |
| Escherichia coli Proteins | 1 | 2017 | 168 | 0.15 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.15 | Why? |
| Pseudomonas Infections | 1 | 2020 | 425 | 0.15 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.15 | Why? |
| Communicable Diseases, Imported | 2 | 2021 | 843 | 0.14 | Why? |
| Bacterial Proteins | 2 | 2017 | 1318 | 0.14 | Why? |
| Microbiological Techniques | 1 | 2016 | 232 | 0.14 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.13 | Why? |
| Genome, Viral | 8 | 2021 | 13157 | 0.13 | Why? |
| Phylogeny | 6 | 2021 | 13341 | 0.13 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2020 | 861 | 0.12 | Why? |
| Travel | 5 | 2021 | 7220 | 0.11 | Why? |
| Family Health | 1 | 2017 | 731 | 0.11 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3633 | 0.11 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.11 | Why? |
| Helicobacter | 1 | 2010 | 7 | 0.11 | Why? |
| Dysbiosis | 1 | 2017 | 685 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.11 | Why? |
| Microsatellite Repeats | 1 | 2010 | 99 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Receptors, Interleukin-1 | 1 | 2009 | 161 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Epidemiological Monitoring | 4 | 2021 | 3493 | 0.08 | Why? |
| Likelihood Functions | 2 | 2020 | 719 | 0.08 | Why? |
| DNA, Viral | 1 | 2018 | 2521 | 0.08 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.08 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.08 | Why? |
| Phylogeography | 2 | 2021 | 824 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.08 | Why? |
| Software | 1 | 2016 | 2501 | 0.07 | Why? |
| Spatio-Temporal Analysis | 2 | 2021 | 1182 | 0.07 | Why? |
| Sequence Analysis, DNA | 3 | 2021 | 2830 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.06 | Why? |
| Bacteria | 2 | 2017 | 1897 | 0.06 | Why? |
| Computational Biology | 2 | 2016 | 4514 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Aspartic Acid | 1 | 2020 | 76 | 0.05 | Why? |
| Bayes Theorem | 2 | 2020 | 3237 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Glycine | 1 | 2020 | 203 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Basic Reproduction Number | 2 | 2021 | 2676 | 0.05 | Why? |
| Brazil | 3 | 2021 | 12582 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.05 | Why? |
| Internet | 1 | 2016 | 6204 | 0.04 | Why? |
| Connecticut | 1 | 2020 | 547 | 0.04 | Why? |
| Protein Conformation | 2 | 2020 | 4386 | 0.04 | Why? |
| Models, Genetic | 1 | 2020 | 434 | 0.04 | Why? |
| Guinea | 1 | 2018 | 228 | 0.04 | Why? |
| Ribotyping | 1 | 2017 | 54 | 0.04 | Why? |
| Genome, Microbial | 1 | 2016 | 12 | 0.04 | Why? |
| Thiophenes | 1 | 2017 | 78 | 0.04 | Why? |
| Fatty Acids, Volatile | 1 | 2017 | 63 | 0.04 | Why? |
| Evolution, Molecular | 2 | 2021 | 3691 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Siblings | 1 | 2017 | 226 | 0.04 | Why? |
| Pseudomonas aeruginosa | 1 | 2020 | 652 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.04 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.04 | Why? |
| Genome, Human | 1 | 2019 | 400 | 0.04 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2017 | 238 | 0.04 | Why? |
| Washington | 1 | 2020 | 1722 | 0.03 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.03 | Why? |
| User-Computer Interface | 1 | 2021 | 1068 | 0.03 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.03 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.03 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.03 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.03 | Why? |
| Furin | 1 | 2020 | 1054 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2017 | 419 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 1115 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.02 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.02 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2010 | 143 | 0.02 | Why? |
| England | 1 | 2021 | 5116 | 0.02 | Why? |
| Genes, Bacterial | 1 | 2010 | 207 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2020 | 6049 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Cities | 1 | 2020 | 4937 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.02 | Why? |
| DNA, Bacterial | 1 | 2010 | 835 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Feces | 1 | 2017 | 4235 | 0.02 | Why? |
| Parents | 1 | 2017 | 2758 | 0.02 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.02 | Why? |
| Animals | 3 | 2020 | 78931 | 0.02 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Contact Tracing | 1 | 2018 | 8448 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Genetic Variation | 1 | 2010 | 3919 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Male | 3 | 2020 | 367725 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Signal Transduction | 1 | 2009 | 7207 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Female | 1 | 2017 | 380317 | 0.00 | Why? |
Loman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(371)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_